Charles River Laboratories | CRL - Market Capitalization


Charles River Laboratories reported $8.36B in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Agilent USD 41.49B 8.93B Sep/2025
Align Technology USD 12.04B 838M Feb/2026
Bio-Rad Laboratories USD 6.7B 908M Feb/2026
Bruker USD 5.69B 1.47B Feb/2026
Cardinal Health USD 54.98B 6.15B Feb/2026
Charles River Laboratories USD 8.08B 1.94B Feb/2026
Cigna USD 80.66B 7.14B Feb/2026
Concord Medical Services Hldg CNY 59.92M 11.29M Jun/2023
CVS Health USD 98.76B 1.98B Feb/2026
Danaher USD 161.7B 29.34B Dec/2025
Dentsply International USD 2.53B 633M Sep/2025
Elevance Health USD 77.91B 5.15B Dec/2025
Galapagos EUR 1.93B 10.54M Feb/2026
Hologic USD 16.62B 1.67B Dec/2025
Humana USD 21.14B 9.66B Feb/2026
Illumina USD 21.21B 588M Feb/2026
Incyte USD 22.7B 3.31B Feb/2026
Intrexon USD 363M 69M Sep/2023
IQVIA Holdings USD 32.84B 5.54B Feb/2026
Laboratory Of America USD 23.77B 2.98B Feb/2026
Lonza CHF 39.68B 980.61M Jun/2025
McKesson USD 108.02B 6.77B Feb/2026
Merck EUR 47.59B 239.13M Sep/2025
Mettler Toledo International USD 29.7B 1.22B Feb/2026
Novartis USD 265.66B 9.48B Sep/2025
Pfizer USD 152.89B 11.32B Feb/2026
Quest Diagnostics USD 23.09B 3.79B Feb/2026
Revvity USD 12.58B 1.61B Feb/2026
Thermo Fisher Scientific USD 217.7B 42.4B Dec/2025
United Therapeutics USD 18.96B 6B Sep/2025
UnitedHealth USD 265.18B 33.84B Feb/2026
Veradigm USD 1.69B 34M Sep/2022
Waters USD 19.14B 3.47B Feb/2026
West Pharmaceutical Services USD 17.83B 1.96B Feb/2026